Bezlotoxumab regulatory update

Merck said FDA extended the PDUFA date to Oct. 23 from July 23 for a BLA for Zinplava bezlotoxumab to

Read the full 205 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE